TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/10/22 16:20 | 11/9/22 | GILD | Gilead Sciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wilfong Diane E. | CA | O | SVP,Cont | S.d | -536 | 83.50 | 0 | -6 | -18 | 28 | D | ||||||||||||||
11/2/22 16:57 | 11/1/22 | GILD | Gilead Sciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wilfong Diane E. | CA | O | SVP,Cont | S.d | -1,288 | 79.25 | 0 | -16 | -36 | 28 | D | ||||||||||||||
8/18/21 19:32 | 8/17/21 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Wilfong Diane E. | CA | O | SVP,Cont | S.d | -987 | 72.50 | 0 | -14 | -40 | 20 | D | ||||||||||||||
5/6/20 18:40 | 5/4/20 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Wilfong Diane E. | CA | O | SVP,Cont | S.d | -982 | 80.09 | 0 | -12 | -52 | 11 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |